Company awaits final Phase 3 data in head and neck cancer (Image: CEL-SCI)
Cel-Sci Corporation (CVM) saw its stock plunge after pricing a public offering of over 7 million shares of stock. Pricing the units at $1.40 apiece for gross proceeds of $10 million. Each unit
Today was a rough day for Internet retailers and service providers. First, Netflix (NASDAQ: NFLX) made headlines with an 8.8 percent drop for the day and now online mega-retailer Amazon
Company chart and information is provided by TradingView based on 15-minute-delayed data.
CEL-SCI Corp is a player in the biotechnology sector. It is engaged in the research and development at developing the treatment of cancer and other diseases by using the immune system. The company is focused on activating the immune system to fight cancer and infectious diseases. It is focused on the development of Multikine (Leukocyte Interleukin, Injection), investigational immunotherapy under development for the treatment of certain head and neck cancers, and anal warts or cervical dysplasia.
| Website: | www.cel-sci.com |
| Email: | gdewindt@cel-sci.com |
| Main Phone: | +1 703 506-9460 |
| Address: | 8229 Boone Boulevard |
| Address 2: | Suite 802 |
| State: | VA |
| City / Town: | Vienna |
| Country: | US |
| Postal Code: | 22182 |
| Exchange: | AMX |
| CEO: | Geert R. Kersten |
| Employees: | 44 |
| NAICS: | Biological Product (except Diagnostic) Manufacturing(325414) |
Company awaits final Phase 3 data in head and neck cancer (Image: CEL-SCI)
Cel-Sci Corporation (CVM) saw its stock plunge after pricing a public offering of over 7 million shares of stock. Pricing the units at $1.40 apiece for gross proceeds of $10 million. Each unit
Today was a rough day for Internet retailers and service providers. First, Netflix (NASDAQ: NFLX) made headlines with an 8.8 percent drop for the day and now online mega-retailer Amazon
| Last Price N/A | Change $ N/A | Change % N/A | Tick N/A |
| Bid N/A | Bid Size N/A | Ask N/A | Ask Size N/A |
| Open N/A | High N/A | Low N/A | Prev Close N/A |
| Last Trade | Volume N/A | 52 Wk Hi N/A | 52 Wk Low N/A |
| Market Cap N/A | Ex-Div Date N/A | Div Rate N/A | Yield N/A |
| Shares N/A | EPS (TTM) N/A | PE Ratio N/A | Exchange N/A |
© 2021 Equities News | Equities.com, Inc.
* All dates and time are being displayed in Eastern Standard Time (EST).
